Abstract
Antigen–antibody complexes in tissues play a central role in the pathogenesis of lupus. Some of the immune complexes are formed in situ, i.e., in the tissues. Others are present in the blood stream, and these circulating immune complexes may deposit in tissues and incite inflammatory mechanisms in those tissues. A variety of techniques are available to measure circulating immune complexes. The assays that have been most studied in SLE include approaches that rely on the interaction of immune complexes with complement proteins, and therefore bind to C1q or contain bound C3.
In the process of investigating circulating immune complexes, it was recognized that lupus patients generate serum autoantibodies directed against C1q and other complement proteins. Antibodies reacting with the collagen-like region of C1q are known to be closely linked both clinically and pathophysiologically to lupus nephritis. This chapter describes methods for detection of C1q-binding immune complexes via the C1q solid-phase assay and the related test for autoantibodies to C1q.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- C1qSP:
-
C1q solid-phase assay for immune complexes
- C1qBA:
-
C1q fluid-phase binding assay for immune complexes
- AHG:
-
Aggregated human IgG
References
Dixon FJ (1963) The role of antigen-antibody complexes in disease. Harvey Lect 58:21–52
Cooper KM, Moore M (1983) Critical aspects of immune complex assays employing polyethylene glycol. J Immunol Methods 60:289–303
Theofilopoulos AN, Dixon FJ (1979) The biology and detection of immune complexes. Adv Immunol 28:89–220
Lambert PH, Dixon FJ, Zubler RH, Agnello V, Cambiaso C, Casali P et al (1978) WHO collaborative study for evaluation of 18 methods for detecting immune-complexes in serum. J Clin Lab Immunol 1:1–15
Cooper KM, Moore M (1983) Reactivity of low molecular weight material in cellular immune complex assays. Clin Exp Immunol 52:407–416
Kohro-Kawata J, Wener MH, Mannik M (2002) The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus. J Rheumatol 29:84–89
Durand CG, Burge JJ (1984) A new enzyme-linked immunosorbent assay (ELISA) for measuring immunoconglutinins directed against the third component of human complement. Findings in systemic lupus erythematosus. J Immunol Methods 73:57–66
Uwatoko S, Mannik M (1988) Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J Clin Invest 82:816–824
Reid KB (1982) C1q. Methods Enzymol 82(Pt A):319–324
Siegert CE, Daha MR, Swaak AJ, Van Der Voort EA, Breedveld FC (1993) The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 67:204–209
Bentwich Z, Bianco N, Jager L, Houba V, Lambert P, Knaap W (1982) Use and abuse of laboratory tests in clinical immunology: critical considerations of eight widely used diagnostic procedures. Report of a joint IUIS/WHO meeting on assessment of tests used in clinical immunology. Clin Immunol Immunopathol 24:122–138
Lloyd W, Schur PH (1981) Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) 60:208–217
Abrass CK, Nies KM, Louie JS, Border WA, Glassock RJ (1980) Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 23:273–282
Wener MH, Uwatoko S, Mannik M (1989) Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum 32:544–551
Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M (2011) Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus 20:1267–1274
Trouw LA, Groeneveld TW, Seelen MA, Duijs JM, Bajema IM, Prins FA et al (2004) Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 114:679–688
Levinson SS, Goldman JO (1987) Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods. J Clin Microbiol 25:1567–1569
Mahler M, Van Schaarenburg RA, Trouw LA (2013) Anti-C1q autoantibodies, novel tests, and clinical consequences. Front Immunol 4:117
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Wener, M.H. (2014). Tests for Circulating Immune Complexes. In: Eggleton, P., Ward, F. (eds) Systemic Lupus Erythematosus. Methods in Molecular Biology, vol 1134. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0326-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0326-9_4
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0325-2
Online ISBN: 978-1-4939-0326-9
eBook Packages: Springer Protocols